First Heartland Consultants, Inc. Astrazeneca PLC Transaction History
First Heartland Consultants, Inc.
- $963 Million
- Q1 2024
A detailed history of First Heartland Consultants, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, First Heartland Consultants, Inc. holds 10,536 shares of AZN stock, worth $811,166. This represents 0.07% of its overall portfolio holdings.
Number of Shares
10,536
Previous 6,357
65.74%
Holding current value
$811,166
Previous $428,000
66.82%
% of portfolio
0.07%
Previous 0.05%
Shares
6 transactions
Others Institutions Holding AZN
# of Institutions
1,247Shares Held
477MCall Options Held
5.99MPut Options Held
5.24M-
Price T Rowe Associates Inc Baltimore, MD61.3MShares$4.72 Billion0.51% of portfolio
-
Wellington Management Group LLP Boston, MA49.1MShares$3.78 Billion0.6% of portfolio
-
Primecap Management CO Pasadena, CA42.9MShares$3.31 Billion2.21% of portfolio
-
Capital International Investors Los Angeles, CA34.5MShares$2.66 Billion0.48% of portfolio
-
Jennison Associates LLC17.3MShares$1.33 Billion0.79% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $239B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...